Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients-Reference-Cited by-同舟云学术

Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients

Published:2018-04-04 Issue:12 Volume:59 Page:2801-2811
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Robinson Tara M.¹,Prince Gabrielle T.¹,Thoburn Chris²,Warlick Erica³,Ferguson Anna¹,Kasamon Yvette L.¹,Borrello Ivan M.¹,Hess Allan¹,Smith B. Douglas¹

Affiliation:

1. Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA;

2. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA;

3. Department of Medicine, University of Minnesota Medical Center, St. Paul/Minneapolis, MN, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1443449

Reference43 articles.

1. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

2. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

3. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

4. Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

5. Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation: From Graft-versus-Host Disease to the Graft-versus-Tumor Effect;Transplantation and Cellular Therapy;2024-04

2. Vaccines: a promising therapy for myelodysplastic syndrome;Journal of Hematology & Oncology;2024-01-08

3. Management of patients with lower-risk myelodysplastic syndromes;Blood Cancer Journal;2022-12-14

4. Electrically regulated cell‐based intervention for viral infections;Bioengineering & Translational Medicine;2022-11-15

5. Antiviral T-cell Biofactory platform for SARS-CoV-2;2022-06-27